Genomic and transcriptomic mediators of ADC resistance in breast cancer
RWD analysis reveals distinct resistance mechanisms for different ADCs in metastatic breast cancer
INDICATION
Breast
BIOMARKER
HER2
Related cases
RWD analysis reveals distinct resistance mechanisms for different ADCs in metastatic breast cancer
Related cases